Alpha Tau Medical to Present at Jefferies Healthcare Conference
Ticker: DRTSW · Form: 6-K · Filed: May 21, 2024 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | May 21, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: conference-presentation, medical-devices
TL;DR
Alpha Tau Medical presenting at Jefferies Healthcare Conference on May 21, 2024.
AI Summary
Alpha Tau Medical Ltd. announced on May 21, 2024, that it will present at the Jefferies Global Healthcare Conference. The company, headquartered in Jerusalem, Israel, is involved in surgical and medical instruments and apparatus.
Why It Matters
Presenting at a major healthcare conference can increase visibility and attract potential investors or partners for Alpha Tau Medical's innovative medical technologies.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a conference presentation and does not contain significant financial or operational news.
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- Jefferies Global Healthcare Conference (company) — Event
- May 21, 2024 (date) — Announcement Date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report that Alpha Tau Medical Ltd. issued a press release on May 21, 2024, announcing their participation in the Jefferies Global Healthcare Conference.
When was the press release issued?
The press release was issued on May 21, 2024.
What is the title of the press release attached to this filing?
The title of the press release is "Alpha Tau to Present at the Jefferies Global Healthcare Conference."
Where is Alpha Tau Medical Ltd. headquartered?
Alpha Tau Medical Ltd. is headquartered in Jerusalem, Israel.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13A-16 or 15D-16 under the Securities Exchange Act of 1934.
Filing Stats: 300 words · 1 min read · ~1 pages · Grade level 10.4 · Accepted 2024-05-21 08:47:04
Filing Documents
- ea0206610-6k_alphatau.htm (6-K) — 14KB
- ea020661001ex99-1_alphatau.htm (EX-99.1) — 5KB
- 0001213900-24-045389.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alpha Tau Medical Ltd. Date: May 21, 2024 By: /s/ Uzi Sofer Uzi Sofer Chief Executive Officer 3